{
    "clinical_study": {
        "@rank": "83782", 
        "arm_group": [
            {
                "arm_group_label": "Lifestyle modification", 
                "arm_group_type": "No Intervention", 
                "description": "Obtaining ideal body weight by calorie restriction diet and programmed physical activity"
            }, 
            {
                "arm_group_label": "H.pylori eradication", 
                "arm_group_type": "Experimental", 
                "description": "H.pylori eradication by quadruple antibiotic therapy for two weeks plus obtaining ideal body weight by calorie restriction diet and programmed physical activity"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of study was to evaluate the effect of helicobacter pylori eradication on liver fat\n      content, liver function tests, lipid profile, homeostasis model assessment-IR (HOMA-IR)\n      index, and anthropometric measurements (body mass index and waist circumference)in\n      non-diabetic subjects with non-alcoholic fatty liver disease."
        }, 
        "brief_title": "Helicobacter Pylori Eradication in Non-diabetic Non-alcoholic Steatohepatitis", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Obtaining ideal body weight by calorie restriction diet and programmed physical activity", 
                            "title": "Lifestyle Modification"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "H.pylori eradication by quadruple antibiotic therapy for two weeks plus obtaining ideal body weight by calorie restriction diet and programmed physical activity", 
                            "title": "H.Pylori Eradication"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "40"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "20"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "20"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "40"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "13.96", 
                                                "@value": "42.90"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "10.14", 
                                                "@value": "41.11"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "12.30", 
                                                "@value": "41.57"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "9"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "11"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "11"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "9"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "20"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "20"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "40"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "Iran, Islamic Republic of"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "All Principal Investigators ARE employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "limitations_and_caveats": "No limitations and Caveats", 
            "outcome_list": {
                "outcome": [
                    {
                        "analysis_list": {
                            "analysis": [
                                {
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O3"
                                        ]
                                    }, 
                                    "method": "t-test, 2 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.94"
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": [
                                            "O2", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "t-test, 2 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.78"
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": [
                                            "O1", 
                                            "O2"
                                        ]
                                    }, 
                                    "method": "Paired t-test", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.01"
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": [
                                            "O3", 
                                            "O4"
                                        ]
                                    }, 
                                    "method": "Paired t-test", 
                                    "non_inferiority": "No", 
                                    "p_value": "<0.01"
                                }, 
                                {
                                    "group_id_list": {
                                        "group_id": [
                                            "O5", 
                                            "O6"
                                        ]
                                    }, 
                                    "method": "t-test, 2 sided", 
                                    "non_inferiority": "No", 
                                    "p_value": "0.10"
                                }
                            ]
                        }, 
                        "description": "Primary outcome measure was changes in the liver fat content from baseline to the end of study (6 weeks post-treatment).\nThe percent of liver fat was calculated as below:\n\u201cLiver fat content (%) = 10 (-0.805 + 0.282 * metabolic syndrome (yes = 1 / no = 0) + 0.078 * type 2 diabetes (yes =2 / no =0) + 0.525 * log fasting serum insulin (mU/L) + 0.521 * log fasting serum AST (U/L) \u2013 0.454 * log (AST/ALT)\u201d", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Liver fat content in Helicobacter pylori eradication plus lifestyle modification group at baseline", 
                                    "title": "Liver Fat Content in H.Pylori Eradication at Baseline"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Liver fat content in Helicobacter pylori eradication plus lifestyle modification group at 8 weeks", 
                                    "title": "Liver Fat Content in H.Pylori Eradication at 8 Weeks"
                                }, 
                                {
                                    "@group_id": "O3", 
                                    "description": "Liver fat content in lifestyle modification group at baseline", 
                                    "title": "Liver Fat Content in Lifestyle Modification at Baseline"
                                }, 
                                {
                                    "@group_id": "O4", 
                                    "description": "Liver fat content in lifestyle modification group at 8 weeks", 
                                    "title": "Liver Fat Content in Lifestyle Modification at 8 Weeks"
                                }, 
                                {
                                    "@group_id": "O5", 
                                    "description": "The change of liver fat content from baseline to the end of study in H.pylori eradication group", 
                                    "title": "Liver Fat Content Change in H.Pylori Eradication"
                                }, 
                                {
                                    "@group_id": "O6", 
                                    "description": "The change of liver fat content from baseline to the end of study in lifestyle modification group", 
                                    "title": "Liver Fat Content Change in Lifestyle Modification"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "19"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "19"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@value": "20"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@value": "20"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@value": "19"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@value": "20"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@spread": "4.47", 
                                                        "@value": "8.38"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@spread": "4.34", 
                                                        "@value": "7.72"
                                                    }, 
                                                    {
                                                        "@group_id": "O3", 
                                                        "@spread": "6.03", 
                                                        "@value": "8.50"
                                                    }, 
                                                    {
                                                        "@group_id": "O4", 
                                                        "@spread": "5.06", 
                                                        "@value": "7.29"
                                                    }, 
                                                    {
                                                        "@group_id": "O5", 
                                                        "@spread": "0.61", 
                                                        "@value": "0.66"
                                                    }, 
                                                    {
                                                        "@group_id": "O6", 
                                                        "@spread": "1.31", 
                                                        "@value": "1.21"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Primary outcome measure was changes in the liver fat content from baseline to the end of study (6 weeks post-treatment).\nThe percent of liver fat was calculated as below:\n\u201cLiver fat content (%) = 10 (-0.805 + 0.282 * metabolic syndrome (yes = 1 / no = 0) + 0.078 * type 2 diabetes (yes =2 / no =0) + 0.525 * log fasting serum insulin (mU/L) + 0.521 * log fasting serum AST (U/L) \u2013 0.454 * log (AST/ALT)\u201d", 
                                    "dispersion": "Standard Deviation", 
                                    "param": "Mean", 
                                    "title": "Liver Fat Content", 
                                    "units": "percentage of liver fat content"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks (6 weeks post-treatment)", 
                        "title": "Liver Fat Content", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in serum alanine aminotransferase concentration from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Serum Alanine Aminotransferase Level", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in serum aspartate aminotransferase concentration from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Serum Aspartate Aminotransferase Level", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in fasting serum glucose concentration from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Fasting Serum Glucose", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in serum lipid profile (including serum  triglyceride, cholesterol, low-density lipoprotein, and high-density lipoprotein concentration) from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Serum Lipid Profile", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in HOMA-IR from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Homeostasis Model Assessment-Insulin Resistance (HOMA-IR)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Secondary outcome measure was change in anthropometric measurements (body mass index and waist circumference) from baseline to the end of study", 
                        "safety_issue": "No", 
                        "time_frame": "8 weeks", 
                        "title": "Anthropometric Measurements", 
                        "type": "Secondary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Obtaining ideal body weight by calorie restriction diet and programmed physical activity", 
                            "title": "Lifestyle Modification"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "H.pylori eradication by quadruple antibiotic therapy for two weeks plus obtaining ideal body weight by calorie restriction diet and programmed physical activity", 
                            "title": "H.Pylori Eradication"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": {
                                "participants_list": {
                                    "participants": [
                                        {
                                            "@count": "0", 
                                            "@group_id": "P1"
                                        }, 
                                        {
                                            "@count": "1", 
                                            "@group_id": "P2"
                                        }
                                    ]
                                }, 
                                "title": "H.pylori eradication not successful"
                            }
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "20", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "20", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "20", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "19", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "0", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "1", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "jamalira@tums.ac.ir", 
                "name_or_title": "Dr Raika Jamali", 
                "organization": "Tehran University of Medical Sciences", 
                "phone": "982163120000 ext 411"
            }
        }, 
        "completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "condition": "Non-alcoholic Fatty Liver Disease", 
        "condition_browse": {
            "mesh_term": [
                "Fatty Liver", 
                "Liver Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "Helicobacter pylori (HP) antigens have been found in the liver of individuals with benign\n      and malignant liver diseases. The role of HP in the pathogenesis of non-alcoholic fatty\n      liver disease (NAFLD) is controversial.\n\n      This randomized double blind clinical trial was performed in non-diabetic dyspeptic patients\n      with positive antibody to HP and the evidence of fatty liver in ultrasonography. After\n      excluding other causes, participants with persistent elevated serum aminotransferase levels\n      were presumed to have NAFLD. Those with NAFLD liver fat score greater than (-0.64) and\n      positive urea breath test (UBT) were enrolled. They were randomly assigned to lifestyle\n      modification alone or lifestyle modification plus HP eradication groups. Quadruple therapy\n      (omeprazole, amoxicillin, bismuth subcitrate, and clarithromycin) for HP eradication was\n      performed in two weeks. HP eradication was documented by UBT. Liver fat content, fasting\n      serum glucose, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase,\n      triglyceride, cholesterol, high and low-density lipoprotein, HOMA-IR, and anthropometric\n      measurements (body mass index and waist circumference) were checked at baseline and six\n      weeks post-treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Dyspeptic patients with positive antibody to H.pylori and persistent elevated\n             aminotransferase levels with the evidence of fatty liver in ultrasonography, who were\n             referred to a gastroenterology clinic.\n\n        Exclusion Criteria:\n\n          -  Alcohol use (more than 20 gram per day in men and 10 gram per day in women per day),\n             diabetes mellitus, heart disease (ischemic or congestive), hepatic disease (viral\n             hepatitis, autoimmune hepatitis, wilson disease, hemochromatosis, liver mass lesion),\n             renal disease (serum creatinine concentration of > 1.5 mg/dl), any severe systemic\n             co-morbidities, neoplasm, using any medication during the past 3 months, previous\n             history of peptic ulcer, previous history of H.pylori eradication, existence of alarm\n             signs (weight loss, dysphagia, anemia, vomiting, positive family history of\n             gastrointestinal cancers), and pregnant or lactating women."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 27, 2012", 
        "firstreceived_results_date": "October 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01654549", 
            "org_study_id": "1391/3/27-573"
        }, 
        "intervention": {
            "arm_group_label": "H.pylori eradication", 
            "description": "Omeprazole (20 mg/BD)+ Amoxicillin (1 g/day)+ Bismuth subcitrate (240 mg/BD)+ Azithromycin (500 mg/BD)", 
            "intervention_name": "H.pylori eradication", 
            "intervention_type": "Drug", 
            "other_name": "H.pylori treatment"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Steatohepatitis,", 
            "Helicobacter pylori,", 
            "Insulin resistance,", 
            "Alanine aminotransferase,", 
            "Aspartate aminotransferase,"
        ], 
        "lastchanged_date": "November 21, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tehran", 
                    "country": "Iran, Islamic Republic of"
                }, 
                "name": "Gastroenterology clinic, Sina hospital."
            }
        }, 
        "location_countries": {
            "country": "Iran, Islamic Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-diabetic Subjects With Non-alcoholic Fatty Liver Disease", 
        "overall_official": {
            "affiliation": "Tehran University of Medical Sciences", 
            "last_name": "Raika Jamali, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Iran: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Primary outcome measure was changes in the liver fat content from baseline to the end of study (6 weeks post-treatment).\nThe percent of liver fat was calculated as below:\n\"Liver fat content (%) = 10 (-0.805 + 0.282 * metabolic syndrome (yes = 1 / no = 0) + 0.078 * type 2 diabetes (yes =2 / no =0) + 0.525 * log fasting serum insulin (mU/L) + 0.521 * log fasting serum AST (U/L) - 0.454 * log (AST/ALT)\"", 
            "measure": "Liver Fat Content", 
            "safety_issue": "No", 
            "time_frame": "8 weeks (6 weeks post-treatment)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01654549"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Tehran University of Medical Sciences", 
            "investigator_full_name": "Raika Jamali", 
            "investigator_title": "Assistant professor of medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Secondary outcome measure was change in serum alanine aminotransferase concentration from baseline to the end of study", 
                "measure": "Serum Alanine Aminotransferase Level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Secondary outcome measure was change in serum aspartate aminotransferase concentration from baseline to the end of study", 
                "measure": "Serum Aspartate Aminotransferase Level", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Secondary outcome measure was change in fasting serum glucose concentration from baseline to the end of study", 
                "measure": "Fasting Serum Glucose", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Secondary outcome measure was change in serum lipid profile (including serum  triglyceride, cholesterol, low-density lipoprotein, and high-density lipoprotein concentration) from baseline to the end of study", 
                "measure": "Serum Lipid Profile", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Secondary outcome measure was change in HOMA-IR from baseline to the end of study", 
                "measure": "Homeostasis Model Assessment-Insulin Resistance (HOMA-IR)", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }, 
            {
                "description": "Secondary outcome measure was change in anthropometric measurements (body mass index and waist circumference) from baseline to the end of study", 
                "measure": "Anthropometric Measurements", 
                "safety_issue": "No", 
                "time_frame": "8 weeks"
            }
        ], 
        "source": "Tehran University of Medical Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Tehran University of Medical Sciences", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}